Collection of Plasma Samples From Individuals Initiating Therapy With Entecavir or Tenofovir for Chronic Hepatitis B Virus Infection for the Clinical Evaluation of the Aptima HBV Quant Assay
Phase of Trial: Phase IV
Latest Information Update: 08 Aug 2018
Price : $35 *
At a glance
- Drugs Entecavir (Primary) ; Tenofovir (Primary)
- Indications Hepatitis B
- Focus Therapeutic Use
- Sponsors Hologic
- 31 Jul 2018 Status changed from active, no longer recruiting to completed.
- 22 Mar 2017 Planned End Date changed from 1 Sep 2018 to 1 Mar 2018.
- 11 May 2016 Planned End Date changed from 1 Mar 2016 to 1 Sep 2018.